Literature DB >> 7058324

An inhibitor of the binding of thyroid hormones to serum proteins is present in extrathyroidal tissues.

I J Chopra, D H Solomon, G N Teco, J B Eisenberg.   

Abstract

Extrathyroidal tissues of man and the rat contain a potent inhibitor of the binding of thyroid hormones to serum proteins and to an anion-exchange resin. The inhibitor is heat-labile and nondialyzable. It acts by reducing the binding affinity of thyroid hormones to serum proteins, not by reducing the number of binding sites. The tissue inhibitor is similar in several characteristics to an inhibitor described previously in the serum of some critically ill patients, suggesting that the tissue inhibitor may leak into the circulation in severe illnesses.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7058324     DOI: 10.1126/science.7058324

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  12 in total

Review 1.  Thyroid emergencies.

Authors:  Nicholas J Sarlis; Loukas Gourgiotis
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

2.  Plasma thyroxine levels in Duchenne muscular dystrophy.

Authors:  H A John
Journal:  Experientia       Date:  1990-03-15

Review 3.  Hormonal changes in non-endocrine disease.

Authors:  C G Semple
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-25

4.  Thyroid hormone levels improve the prediction of mortality among patients admitted to the intensive care unit.

Authors:  Erick Chinga-Alayo; Jaime Villena; Arthur T Evans; Mirko Zimic
Journal:  Intensive Care Med       Date:  2005-07-13       Impact factor: 17.440

Review 5.  Euthyroid hyperthyroxinemia.

Authors:  R Rajatanavin; L E Braverman
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

6.  Persistence of low serum thyroid hormone levels in a Graves' disease patient receiving supraphysiologic L-thyroxine replacement therapy.

Authors:  B N Premachandra; T W Burns; R Bregant; I K Williams; K D Burman
Journal:  J Endocrinol Invest       Date:  1989-12       Impact factor: 4.256

7.  Assessment of calcium homeostasis in the critically ill surgical patient. The diagnostic pitfalls of the McLean-Hastings nomogram.

Authors:  G P Zaloga; B Chernow; D Cook; R Snyder; M Clapper; J T O'Brian
Journal:  Ann Surg       Date:  1985-11       Impact factor: 12.969

8.  Inhibition of phagocytosis and chemiluminescence in human leukocytes by a lipid soluble factor in normal tissues.

Authors:  T S Huang; R E Hurd; I J Chopra; P Stevens; D H Solomon; L S Young
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

Review 9.  Nonthyroidal illness syndrome in children.

Authors:  Seth D Marks
Journal:  Endocrine       Date:  2009-09-25       Impact factor: 3.633

Review 10.  [Non-thyroid illness" or changed thyroid hormone parameter syndrome with non-thyroid illnesses].

Authors:  W Reinhardt; K Mann
Journal:  Med Klin (Munich)       Date:  1998-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.